Skip to content
DraconiticResearch
Search Sources API
210,423 studies31 sourcesUpdated 16 min ago

Oncology

5,311 studies490 in 7 days2,547 in 30 days

Filters
Type
Date
Clear

Latest

5,311 studies

  1. Development and internal validation of a prognostic nomogram for cancer-specific survival in Ewing sarcoma: a SEER-based study
    Shilong Wang, Long Jia
    Translational Cancer ResearchPeer-reviewedCC BY-NC-ND 4.0Full textOncologyPMC
  2. Nomograms predicting overall survival and cancer-specific survival in patients with squamous cell carcinoma based on the Surveillance, Epidemiology, and End Results (SEER) database
    Ying Peng, Zhixiong Chen
    Translational Cancer ResearchPeer-reviewedCC BY-NC-ND 4.0Full textOncologyPMC
  3. Spatial transcriptomics reveals PDIA6 as a tumor-intrinsic driver of mesenchymal plasticity and vascular microenvironment remodeling in glioblastoma.
    Changyang Zuo, Guozheng Zhao, Jie Lu +4
    Translational cancer researchPeer-reviewedCC BY-NC-NDFull textOncologyEurope PMCPMC
  4. Network perturbation of lactate metabolism identifies an aggressive hepatocellular carcinoma subtype with distinct immune and microbial features.
    Tao Guo, Huahua Du
    Translational cancer researchPeer-reviewedCC BY-NC-NDFull textOncologyEurope PMCPMC
  5. A survival-informed CD8⁺ T cell-associated gene signature and its prognostic relevance in clear cell renal cell carcinoma.
    Hui Wang, Fan Li, Yi Lu +1
    Translational cancer researchPeer-reviewedCC BY-NC-NDFull textOncologyEurope PMCPMC
  6. TMBIM4 acts as a novel prognostic biomarker for glioblastoma and is associated with temozolomide chemoresistance.
    Jianeng Pu, Tianhua Li, Shuai Zhou +1
    Translational cancer researchPeer-reviewedCC BY-NC-NDFull textOncologyEurope PMCPMC
  7. A novel tumor cell origin-based risk score (TCOMRS) to predict liver metastasis and guide treatment in colon adenocarcinoma.
    Liping Gao, Lingxiu Zeng, Yabing Huo +3
    Translational cancer researchPeer-reviewedCC BY-NC-NDFull textOncologyEurope PMCPMC
  8. Development and external validation of an 18-gene tertiary lymphoid structure-related prognostic signature in gastric cancer.
    Xiaying Han, Qimiao Chen, Zhixing Hao +3
    Translational cancer researchPeer-reviewedCC BY-NC-NDFull textOncologyEurope PMCPMC
  9. Antibody-drug conjugates in the perioperative treatment of resectable non-small cell lung cancer: a narrative review of research advances and prospects.
    Ying Xiong, Lu Sun, Yi Peng
    Translational lung cancer researchPeer-reviewedCC BY-NC-NDFull textOncologyEurope PMCPMC
  10. A 5-gene mutation signature predicts response to atezolizumab in metastatic bladder urothelial carcinoma.
    Dongmei Han, Caihong Wu, Dan Wang +2
    Translational andrology and urologyPeer-reviewedCC BY-NC-NDFull textOncologyEurope PMCPMC
  11. Exploring immunotherapy resistance in bone metastasis: mechanisms and optimization of combined treatment strategies-a narrative review.
    Junquan Zhu, Min Li
    Translational cancer researchPeer-reviewedCC BY-NC-NDFull textOncologyEurope PMCPMC
  12. Therapeutic value of PD-1/PD-L1 blockade plus chemotherapy in advanced or metastatic triple-negative breast cancer: a systematic review and meta-analysis of randomized controlled trials.
    Wanli Qian, Guozhong Chen, Xiaohe Cai +1
    Translational cancer researchPeer-reviewedCC BY-NC-NDFull textOncologyEurope PMCPMC
  13. Emphysema reprograms neutrophils toward a tumor-promoting phenotype in lung cancer.
    Mohamad Qaisi, Merav E Shaul, Nuha Alsharif +5
    Translational lung cancer researchPeer-reviewedCC BY-NC-NDFull textOncologyEurope PMCPMC
  14. Comprehensive multi-omics analysis identifies molecular subtypes and AMH-dependent mechanisms driving DTX resistance in prostate cancer.
    Liang Huang, Shusuan Jiang, Gongqian Zeng +3
    Translational andrology and urologyPeer-reviewedCC BY-NC-NDFull textOncologyEurope PMCPMC
  15. Efficacy and safety of stereotactic body radiotherapy combined with immune checkpoint inhibitors for non-small cell lung cancer: a systematic review and reconstructed individual patient data meta-analysis.
    Pengfei Ji, Zhihui Zhao, Xinpu Tang +7
    Translational lung cancer researchPeer-reviewedCC BY-NC-NDFull textOncologyEurope PMCPMC
  16. Metastatic pulmonary ETV6::NTRK3 mucinous adenocarcinoma originating from an intraductal papillary mucinous neoplasm case report.
    Nicholas P Giustini, Eric Q Konnick, Troy Hutchens +1
    Journal of gastrointestinal oncologyPeer-reviewedCC BY-NC-NDFull textOncologyEurope PMCPMC
  17. Impact of intraoperative retrograde transhepatic biliary drainage on clinically relevant postoperative pancreatic fistula following pancreaticoduodenectomy: a retrospective cohort study.
    Kilhwan Kim, Sanghyun Song, Sungho Jo
    Gland surgeryPeer-reviewedCC BY-NC-NDFull textOncologyEurope PMCPMC
  18. Prognostic and predictive biomarkers in colorectal cancer: from established molecular markers to Mediator complex-related transcriptional reprogramming-a narrative review.
    Mengqian Han, Yijia Mao, Haidong Cheng
    Journal of gastrointestinal oncologyPeer-reviewedCC BY-NC-NDFull textOncologyEurope PMCPMC
  19. Development and cross-cohort evaluation of a DLX4-associated epithelial-mesenchymal transition pathomics signature for overall survival in clear cell renal cell carcinoma.
    Guangli Fang, Xinmiao Bao, Jingyu Chang +2
    Translational andrology and urologyPeer-reviewedCC BY-NC-NDFull textOncologyEurope PMCPMC
  20. Radiologically similar bilateral multifocal renal tumours with discordant pathology: a case report of fat-poor angiomyolipoma and contralateral chromophobe renal cell carcinoma.
    Keha Ma, Chunlei He, Linmao Zheng +6
    Translational andrology and urologyPeer-reviewedCC BY-NC-NDFull textOncologyEurope PMCPMC
  21. Eriodyctiol induces P53-dependent apoptosis in pancreatic cancer through disruption of MDM2-P53 interaction and synergistically enhances gemcitabine efficacy.
    Zhe Liu, Long Yang, Xiaorong Zhu +3
    Translational cancer researchPeer-reviewedCC BY-NC-NDFull textOncologyEurope PMCPMC
  22. Joint neutrophil-to-lymphocyte ratio-systemic inflammation response index score as an independent prognostic biomarker for immunotherapy-treated intrahepatic cholangiocarcinoma.
    Kena Lian, Honggang Cao, Zizhuang Si +2
    Translational cancer researchPeer-reviewedCC BY-NC-NDFull textOncologyEurope PMCPMC
  23. Development and temporal validation of a pathology-based model incorporating the lymph node ratio to predict recurrence in stage III colorectal cancer.
    Jiahui Gu, Qiuyu Chen, Jiaying Xiong +1
    Journal of gastrointestinal oncologyPeer-reviewedCC BY-NC-NDFull textOncologyEurope PMCPMC
  24. Prognostic value of neutrophil-to-lymphocyte ratio in renal cell carcinoma: an updated systematic review and meta-analysis.
    Zhenglei Luo, Zhenxiang Lin, Xiaofang Chen +1
    Translational andrology and urologyPeer-reviewedCC BY-NC-NDFull textOncologyEurope PMCPMC
  25. A non-small cell lung cancer-associated circulating nine-microRNA signature for non-invasive lung cancer detection: integrated bioinformatics, machine learning, external validation, and exploratory regulatory network analysis.
    Qiuyue Wu, Penglong Zhao, Qian Wan +3
    Translational cancer researchPeer-reviewedCC BY-NC-NDFull textOncologyEurope PMCPMC